Polyp biopsy market seen climbing to $2.06B by 2030

The polyp biopsy market is projected to grow from $1.39 billion in 2025 to $1.5 billion in 2026, then reach $2.06 billion by 2030, according to a new market report from The Business Research Company. Rising colorectal cancer cases, wider screening and advances in endoscopy are driving demand across hospitals, labs and specialty clinics.

Why it matters: - Polyp biopsy procedures help detect whether a polyp is benign or malignant, shaping diagnosis, treatment and follow-up care. - Rising colorectal cancer rates are pushing demand for early detection and histopathology services. - The market outlook suggests continued investment in biopsy tools, imaging integration and minimally invasive diagnostics.

What happened: - The Business Research Company released its Polyp Biopsy Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report pegs the polyp biopsy market at $1.39 billion in 2025 and $1.5 billion in 2026. - The report forecasts the market will reach $2.06 billion by 2030. - North America held the largest regional share in 2025. - Asia-Pacific is expected to grow the fastest over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - The market grew at an 8.5% compound annual growth rate in the recent period. - The forecast period implies an 8.2% CAGR through 2030. - Growth drivers include rising gastrointestinal and cervical cancers, advances in endoscopic technology, more screening programs, greater awareness of early diagnosis and growth in specialty clinics. - Future growth is tied to AI-assisted biopsy techniques, minimally invasive procedures, broader use in hospitals and diagnostic labs, integration with imaging and cloud platforms, and new biopsy instruments. - The report highlights colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy and endoscopic mucosal resection as key trends. - A polyp biopsy is the removal of a small tissue sample from a polyp on an organ or body-cavity lining for microscopic examination. - The sample is used to assess cellular makeup, detect disease and support diagnosis. - Polyp biopsies help distinguish benign from malignant growths and guide treatment and surveillance plans. - Colorectal cancer is a major growth driver because biopsy procedures support early detection and detailed analysis of suspect polyps. - The American Cancer Society projects about 107,320 new colon cancer cases, 46,950 rectal cancer cases and 52,900 deaths in the U.S. in 2025.

Between the lines: - The report points to a diagnostic market benefiting from both higher cancer incidence and broader adoption of tech-enabled procedures. - North America’s lead suggests mature screening infrastructure, while Asia-Pacific’s faster growth points to expanding access and diagnostic capacity. - The emphasis on AI, imaging and cloud-based workflows signals a shift toward more connected pathology and endoscopy systems.

What's next: - The market is expected to keep expanding as hospitals and labs adopt newer biopsy tools and digital workflows. - Regional competition is likely to intensify as Asia-Pacific markets scale screening and diagnostic services. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspot infographics and updated visuals. - The Business Research Company lists contact details for expert inquiries and social media channels, including LinkedIn and other social links in the source material.

The bottom line: - Polyp biopsy demand is rising on the back of cancer screening needs, and the market outlook points to steady growth through 2030.